分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Glucose hypometabolism and hyperphosphorylated Tau synergistically drive neuronal necroptosis

Xiaoshi Chen, Sixuan Li, Antonia Neubauer, Xiang Li, Wei Mao, Matthias Brendel, Jixuan Liu, Mengmeng Zhang, Chongzhe Yang, Ruisheng Xu, Jianping Liu, Bing Shan, Junying Yuan, Cong Liu, Jochen Herms,

Journal:NEURON

IF:16.9

DOI:10.1016/j.neuron.2026.03.035

PMID:42025167

Published:2026-04-22

research field:神经科学分子生物学代谢神经退行性疾病细胞死亡

Abstract

The combination of brain glucose hypometabolism and hyperphosphorylated Tau (p-Tau) pathology is the strongest known clinical predictor of imminent cognitive decline, yet how these factors cooperate to drive dementia remains unknown. Here, we show that glucose hypometabolism synergizes with p-Tau to trigger neuronal loss through necroptosis. Under low-glucose conditions, accumulated p-Tau forms a molecular scaffold that directly recruits RIPK1, while concomitant loss of the necroptosis checkpoint A20 removes a critical brake on this death pathway. This dual mechanism thereby precipitates neuronal necroptosis. Restoring A20 expression with acetyl-L-carnitine or preventing the p-Tau-RIPK1 interaction using a RIPK1-derived competitive peptide alleviates neuronal necroptosis and brain atrophy in a Tau transgenic mouse model. Collectively, our findings uncover a previously unrecognized metabolism-driven necroptotic signaling cascade initiated by a p-Tau-RIPK1 hub, providing mechanistic insight into how glucose hypometabolism synergizes with p-Tau to drive neurodegeneration.

本文使用的Yeasen产品

购物车
客服
转染试用